| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 67.18% | -8.81% | 5.19% | 29/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 63.87% | -14.98% | -7.74% | 43/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 69.22% | -1.36% | -2.12% | 29/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 70.72% | 4.85% | -4% | 20/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 73.67% | 7.05% | -1.93% | 15/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 75.12% | 15.72% | 7.05% | 17/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 70.17% | 3.48% | 4.04% | 27/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 67.45% | -1.11% | -1.99% | 37/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 68.82% | 4.93% | 6.01% | 34/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 64.92% | 1.1% | -4.28% | 44/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 67.82% | 3.29% | -0.57% | 34/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 68.21% | 0.1% | 4% | 35/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 65.58% | -4.64% | 2.14% | 42/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 64.21% | 0.07% | -2.21% | 46/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 65.66% | -3.42% | -3.64% | 40/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 68.14% | -0.61% | -0.92% | 35/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 68.77% | -6.05% | 7.19% | 33/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 64.16% | -14.5% | -5.62% | 44/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 67.98% | -11.7% | -0.84% | 43/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 68.56% | -4.18% | -6.35% | 37/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 73.21% | 2.94% | -2.45% | 31/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 75.05% | 18.17% | -2.53% | 22/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 76.99% | -9.36% | 7.6% | 25/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 71.55% | 2% | 0.62% | 27/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 71.11% | -12.02% | 11.98% | 32/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 63.51% | 2% | -25.24% | 33/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 84.95% | 11.59% | 5.09% | 10/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-06-30 | 80.83% | 8.38% | 6.18% | 12/141 | 57.93% | 正海生物 | 93.78% | 行业排名> |
| 2018-12-31 | 76.12% | 13.26% | 2.07% | 27/141 | 56.22% | 正海生物 | 93.09% | 行业排名> |
| 2018-06-30 | 74.58% | 20.69% | 10.96% | 12/141 | 53.06% | 正海生物 | 93.85% | 行业排名> |
| 2017-12-31 | 67.21% | 43.87% | 8.77% | 39/141 | 56.1% | 正海生物 | 93.08% | 行业排名> |
| 2017-06-30 | 61.79% | 203.59% | 32.27% | 26/141 | 54.85% | 正海生物 | 92.83% | 行业排名> |
| 2016-12-31 | 46.72% | 1.45% | 129.52% | 50/141 | 57.35% | 正海生物 | 92.44% | 行业排名> |
| 2016-06-30 | 20.35% | 2% | -55.8% | 49/141 | 52.6% | 正海生物 | 92.7% | 行业排名> |

微信公众号
证券之星APP


